Today
Like it or not, you’re already being cloned
We’re not all as photogenic as Demi Moore, but genetic data-doubles are becoming par for the course.
- Simon Ings
Navis Capital’s Device Tech stocks up M&A war chest
Street Talk understands Device Tech’s lenders have blessed the pan-Asian buyout firm’s decision to raise $150 million in fresh debt to fund M&A.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Yesterday
- Updated
- Healthcare
Sigma shares surge as it offers concessions for Chemist Warehouse deal
The pharmacy retailer and wholesaler says its franchisees will be allowed to leave without being penalised if it secures the $8.8 billion merger.
- Updated
- Michael Smith
ResMed projects high single-digit revenue growth until 2030
The sleep devices giant expects revenue to grow in the high single-digits for the next five years as it deflects the Ozempic effect.
- Michael Smith
September
Pacific Smiles board set to reject Genesis’ $300m bid
Street Talk understands the dental chain’s board will reject Genesis’ $1.90 per share bid later today.
- Sarah Thompson, Kanika Sood, e and Emma Rapaport
I-MED bidders wrap their heads around data breach
The Permira-owned radiology giant has been the subject of media reports alleging data breaches and misuse of patient data.
- Sarah Thompson, Kanika Sood and Emma Rapaport
‘At tipping point’: Inside one of Australia’s busiest hospitals
Doctors and nurses in Australia’s busiest emergency ward say the system is under unprecedented pressure amid a surge in mental illness and geriatric patients with nowhere else to go.
- Michael Smith
Meet the AC/DC-loving chief doctor who eats by example
Outgoing Australian Medical Association president Steve Robson says prevention is the only cure for Australia’s sick health system.
- Michael Smith
Medical entrepreneur’s R&D finance shop kicks off $100m capital raise
Sources said the firm is busy talking to family offices and institutional debt funds to fund its loan book.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Pro Medicus’ billionaire boss says simplicity secret of success
Pro Medicus’ stranglehold on cloud-imaging healthcare tech means its growth trajectory has a long way to go.
- Michael Smith
Telix on $1b spending spree to build US radiopharmacy network
The biotech is investing heavily in global networks that will enable it to control the supply and distribution of nuclear medicines used to treat cancer.
- Michael Smith
Tanarra Capital says at $835m the price is right for Healius
Shares in the pathology company jumped 7.5 per cent after it achieved a robust price for Lumus, which does MRI, X-rays and CT scans.
- Simon Evans
Is private equity unhealthy for our hospitals?
Billions of dollars have poured into healthcare assets over the past decade. Some warn that style of investing is incompatible with essential services.
- Michael Smith
The five pharma stocks exciting investors
Risky but with rewards, Australian pharmaceutical companies developing treatments for rare diseases are competing for investor attention.
- Michael Smith
PEP bankers up for aged care giant Opal HealthCare; lobs bid
Pacific Equity Partners’ secure assets team has put in a non-binding indicative offer for the $200 million-a-year business.
- Sarah Thompson, Kanika Sood and Emma Rapaport
- Exclusive
- Mergers & acquisitions
John Wylie’s Tanarra urges Healius to halt $700m imaging business sale
The country’s second-largest pathology group has been considering selling its Lumus division. But the outspoken investor says it’s going too well to offload.
- Simon Evans
Pacific Smiles’ 11pc shareholder backs Genesis $300m bid
Street Talk understands fund manager Spheria Asset Management intends to lend its considerable support to Genesis Capital’s new offer.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Airtree-backed NDIS start-up Kismet clinches $32.5m in seed round
Venture capital firm Prosus, MassMutual and Airtree led the round, which was split into two distinct parts.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Australian health start-up chases $1.5b valuation with testing app
Helfie AI wants to transform the way people detect everything from COVID-19 to tuberculosis, using a smartphone. It is aiming to raise at least $150 million.
- Sarah Thompson, Kanika Sood and Emma Rapaport
Why big pharma wants the government to pay it to make drugs
Drug companies say the government must help pay for new antibiotics people will rarely use. But without them, Australians may die.
- Michael Smith
